Concepedia

Aparna Padiyar

AP

Statistics

Publications

11

Citations

757

H-Index

10

Active since

2004

Affiliations

University Hospitals Cleveland Medical Center(Current)

University of Oxford

MetroHealth Medical Center

Case Western Reserve University

Aparna Padiyar is an author at University Hospitals Cleveland Medical Center specializing in medicine, kidney transplantation, and nephrology.

Publications per year

2004–2023

11

Publications

11

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 215 citations · Full text

, , +12

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

, , +11

Independent of Nephrectomy, Weaning Immunosuppression Leads to Late Sensitization After Kidney Transplant Failure

Joshua J. Augustine, Kenneth J. Woodside, Aparna Padiyar et al. · Transplantation · 2012 · 100 citations

, , +17

A WT1 Co-regulator Controls Podocyte Phenotype by Shuttling between Adhesion Structures and Nucleus

Manakan B. Srichai, Martha Konieczkowski, Aparna Padiyar et al. · Journal of Biological Chemistry · 2004 · 90 citations · Full text

, , +13

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

, , +14

1–5 of 11